Jennifer Feng

Partner Investment Funds
Kirkland & Ellis

Hong Kong +852-3761-9114

Jennifer Feng

Practices

Overview

Jennifer Feng is a private investment funds partner in the Hong Kong office of Kirkland & Ellis International LLP.

Jennifer has experience in various areas of corporate law, in particular, in advising international and regional clients in structuring and forming private investment funds as well as subsequent matters related to those funds.

  • Advised Panacea Venture in the formation of its debut USD healthcare fund, Panacea Venture Healthcare Fund I
  • Advised C-Bridge Capital in the formation of its fourth flagship healthcare buyout fund
  • Advised Lilly Asia Ventures (LAV), a leading biomedical venture capital firm, on the formation of LAV Biosciences Fund V (US$750 million)
  • Advised Orchid Asia, an independent Chinese private equity firm, in the formation of its seventh private equity fund (c. US$1.3 billion) and its sixth private equity fund (c. US$920 million)
  • Advised EMR Capital, a specialist mining private equity manager, in the formation of its second private equity fund (c. US$860 million)
  • Advised an independent Chinese venture capital firm specializing in life sciences and healthcare, in the formation of its third (US$300 million) and fourth (US$450 million) life sciences venture fund
  • Advised Creador, an independent South East Asia private equity firm, in the formation of its third private equity fund (c. US$415 million)
  • Advised CD Capital, a specialist natural resources and mining private equity manager, in the formation of its third private equity fund (c. US$355 million)
  • Advised The Growth Fund, an independent Australian private equity firm, on the formation of The Growth Fund 3 (A$450 million)
  • Advised Vision Knight Capital, an independent Chinese private equity firm, in the formation of its second China private equity fund (US$550 million)
  • Advised L Capital Asia, the Asian private equity arm of Louis Vuitton Moët Hennessy, in its second private equity fund (c. US$1 billion)
  • Advised Crescent Point Group, a South East Asia investment firm specializing in special situations investments, on the formation of its (i) consumer and special opportunities private sleeve fund (US$198 million) and (ii) consumer and special opportunities institutional sleeve fund (US$165 million)
  • Advised Saratoga Capital, an independent Indonesian private equity firm, on the formation of Saratoga Asia III (US$600 million)
  • Advised Pacific Road Capital Management, a specialist mining private equity firm, on the formation of Pacific Road Resources Fund II (US$475 million)
  • Advised Archer Capital, an independent Australian private equity firm, on the formation of Archer Capital Fund 5 (A$1.5 billion) and Archer Capital Growth Fund 2 (A$300 million)
Kirkland & Ellis International LLP, London, United Kingdom
  • Associate, 2015–2017

  • Trainee Solicitor, 2010–2012

Kirkland & Ellis, Hong Kong
  • Associate, 2012–2015

More

Credentials

Admissions & Qualifications

  • 2017, Hong Kong, Registered Foreign Lawyer
  • 2012, Admitted to Practice as a Solicitor of England and Wales

Languages

  • Cantonese
  • English
  • Mandarin

Education

  • College of Law, LondonLPCwith Distinction2010
  • University of Nottingham2009